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ABSTRACT
A positive cis-acting DNA element in the near
5'-upstream region of the CYP2B1/B2 genes in rat liver
was found to play an important role in the transcription
of these genes. An oligonucleotide covering - 69 to
- 98 nt mimicked the gel mobility shift pattern given
by the fragment - 179 to + 29 nt, which was earlier
found adequate to confer the regulatory features of this
gene. Two major complexes were seen, of which the
slower and faster moving complexes became intense
under uninduced and Phenobarbitone-induced
conditions respectively. Minigene cloned DNA plasmid
covering -179 to + 181 nt in pUC 19 and Bal 31
mutants derived from this parent were transcribed in
whole nuclei and cell free transcription extracts and
mutants containing only upto - 75 nt of the upstream
were poorly transcribed. Transcription extracts from
phenobarbitone-injected rat liver nuclei were
significantly more active than extracts from uninduced
rats in transcribing the minigene constructs. Addition
of the oligonucleotide (-69 to - 98nt) specifically
inhibited the transcription of the minigene construct
(- 179 to + 181 nt) in the cell free transcription system.
It is therefore, concluded that the region - 69 to - 98
nt acts as a positive cis-acting element in the
transcription of the CYP2B1/B2 genes and in mediating
the inductive effects of phenobarbitone.
INTRODUCTION
The cytochrome P450 group of proteins constitutes a multi gene
family and many of the subfamilies are inducible (1,2). For
example, CYPlAl subfamily in rat liver is induced by polycyclic
aromatic hydrocarbons and a significant amount of information
in terms of the cis-acting DNA elements and their organization
is available. These elements include the xenobiotic responsive
element (3,4) and the basal transcription element (5). An overall
mechanism for the transcriptional activation of the CYPlAl gene
by the inducers involving the Ah receptor and its binding to the
upstream elements has also been proposed (6,7). However, the
mechanism of transcriptional activation of another cytochrome
P-450 family, namely the CYP2B1/B2 genes, which are nearly
97% homologous in the coding and upstream regions (2), by the
prototype drug, Phenobarbitone (PB) is not clear. Towards this
objective, we have been involved in identifying the upstream cis-
acting DNA elements of the CYP2B1/B2 genes in rat liver. We
have earlier shown that the near 5' upstream region of the
CYP2B1/B2 genes (upto - 179nt) can mediate the different
features of transcriptional regulation of this gene family and
nuclear extracts from drug treated livers generate a foot-print
between -54 and -89 nt (8). In the present study, we report
the identification and characterization of a positive cis-acting
element overlapping the foot-print region that is necessary for
the expression of this gene.
MATERIALS AND METHODS
DNA fragments and probes
The plasmid pP450e179, same as pP450e4 reported earlier (8),
containing 360 nt of the cytochrome P450 (2B2) gene and
covering positions - 179 nt to + 181 nt was digested with Bam
H1 (polylinker site at the 5' end) and digested with Bal31 to
generate mutants containing - 116 nt (pP450el 16) and -75 nt
(pP450e75) of the 5'-upstream sequence. The plasmid containing
the promoter region of Phosphoenolpyruvate carboxy kinase
(PEPCK) gene of rat liver (-490 nt to +73 nt) (9) was obtained
as a gift from Dr.R.W.Hanson.
The following oligonucleotides and primers were synthesized
using Gene Assembler Plus, Pharmacia: Oligonucleotide-l
(5'-GAGGAGTGAATAGCCAAAGCAGGAGGCGTG-3'
covering -98 to -69 nt of the CYP2B2 gene and its
complementary sequence); Oligonucleotide -2 (5'-TTTTGTC-
CTGTGTATCTGTTTCGTGGTGTCCTTG-3' covering -160
to -127 nt of the CYP2B2 gene and its complementary
sequence). Primer-I (5'-CACGCCTCCT-3' complementary to
oligonucleotide -1 at the 3' region); Primer-2 (5'-TGGTGTA-
ACCACGGT-3') complementary to the CYP2B1/B2 RNA
transcript from +11 to +26nt); Primer-3 (5'-GACTCAGAG-
CGTCTCGCCGG-3' complementary to the PEPCK RNA
transcript from +51 to +70 nt).
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Gel retardation assay
Nuclei were prepared using citric acid buffer homogenisation (10)
and nuclear extracts were prepared using 0.45 M NaCl (in final
concentration) and dialysis (8). The nuclear extract (1-5 itg
protein) was incubated with 300 ng to 1 ,ug of Poly (dl). Poly
(dC) (double stranded, average length varying from 250 to 350
nt in different commercial preparations) in a volume of 20 pl
containing 25 mM HEPES.NaOH, pH7.5, 5mM MgCl2, 2mM
dithiothreitol and 50mM NaCl at 25°C for 10 min. Labeled NcoI-
Bam HI fragment (-179 to +29 nt) of the CYP2B2 gene
(10,000cpm) or oligonucleotide-1 was then added and incubation
continued for another 30 min. The plasmid pP450e179 was cut
with NcoI, labeled at the 3' end with klenow polymerase and
then the fragment (+29 to -179 nt) released using Bam HI
(polylinker site). Chase experiments were carried out by adding
100 to 500 fold excess of non-radioactive DNA fragments. After
incubation, 2 ,ul of loading buffer (0.05% Bromophenol blue in
50% glycerol) was added and the samples were analysed on low
ionic strength 6% or 9% polyacrylamide gels (8).
U.V. Crosslinking experiments
This was carried out as described by Gallinari et al (9).
Oligonucleotide-1 was annealed with primer-I and then incubated
in the presence of 50 AM each of 5-Br-dUTP, dATP, dGTP and
50 itCi of [a-32P]dCTP (3000 Ci/mmole) for 1 hr at 37'C in
a 25 Al reaction mixture containing 10 mM Tris-HCl, pH 8.0,
10 mM MgCl2, 10 mM dithiothreitol and Klenow polymerase.
The body labeled oligonucleotide was purified by electrophoresis
on 16% polyacrylamide gels. Labeled DNA (2 x 105 cpm) was
incubated with nuclear extract (10 jtg protein) and 5 jig of poly
(dI). poly (dC) in a total volume of 40 ,1l as described for gel
retardation assay.
The complexes were electrophoresed on a low ionic strength
9% non-denaturing gel. The gel was then U.V.irradiated
(1600 w, 260 nm) for 20 to 50 min at 4'C and autoradiographed
overnight. Gel slices corresponding to both the complexes were
soaked in 100 Al of a solution containing DNase I (10 Atg),
micrococcal nuclease (10 units), CaCl2 (10 mM) and MgCl2 (10
mM). The digestion was carried out at room temperature for 30
min and the reaction was terminated by the addition of EDTA
and EGTA (25 mM). The crosslinked complexes were
electroeluted in Tris-glycine-SDS buffer and precipitated with
cold acetone. The pellet was dissolved in SDS-PAGE buffer and
electrophoresed on 10% gels.
Transcription of Bal3l mutants in whole nuclei
The plasmids pP450e 179, pP450e 156, pP450el 16 and pP450e75
were transcribed in frozen thawed rat nuclei as described earlier
(8). The RNA transcripts were isolated and analysed by
SI -nuclease protection assay using labeled NcoI-EcoRI (+29 to
+ 199nt) fragment isolated from pP45Oe179. This fragment
includes 18 nt of the polylinker region and therefore can help
to distinguish the transcripts generated from the externally added
pP45Oe179 DNA and the endogenous CYP2B1/B2 transcripts.
The former generates a 170 nt protected fragment, whereas the
latter a 152 nt protected fragment by virtue of not having the
18 nt polylinker region. The protected fragments were analysed
on urea-polyacrylamide (8%) gels and subjected to auto-
radiography.
Transcription in cell-free extracts
Transcription extracts were prepared from liver nuclei from
control and PB treated rats as described by Gorski et al( 12), with
minor modifications. The repeat layering of nuclei on sucrose
gradient was omitted. Briefly, the nuclear pellets were extracted
with buffer containing 0. lM KCI and other components,
subjected to (NH4)2So4 fractionation and then taken in buffer
containing 25 mM HEPES, pH 7.6, 40 mM KCl, 0.1 mM
EDTA, 1mM dithiothreiotol, 10% glycerol and dialysed twice
against the same buffer. The aliquots (5-8 mg protein/ml) were
quick frozen and stored at -80°C.
Transcription reactions were carried out in a volume of 20 tl
containing 50,ug/ml of supercoiled DNA template, 5 mg
protein/ml of transcription extract, 25 mM HEPES, pH 7.0. 50
mM KCl, 6 mM MgCl2, 0.6 mM each of ATP, GTP, CTP,
UTP and glycerol (12% in final concentration) and 30 units of
ribonuclease inhibitor (Rnasin). In some experiments 0.45M NaCl
nuclear extract (crude nuclear extract) was also added. The
mixture was incubated at 30°C for 45 min. The RNA transcripts
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Figure. 1. Gel mobility shift analysis with the fragment -179 to +29 nt.
pP450el79 was cut with NcoI at +29, end labeled and the fragment released
with Hind III at the polylinker site. The labeled fragment was incubated with
PB-nuclear extracts and analysed for the gel retarded complexes. The fragments
used in chase experiments were generated from Bal31 mutants with NcoI and
HindII. (a) 1-No chase; 2,3 & 4-chased with 100 fold excess of non-radioactive
fragments - 179 to +29nt, - 1 16 to +29 nt and -75 to +29 nt respectively.
(b) 1-No chase; 2-chased with 200 fold excess of oligonucleotide- 1; 3-chased
with 200 fold excess of oligonucleotide-2; 4-free DNA. B-Bottom complex;
T-Top complex.
Figure 2. Gel mobility shift analysis with the fragment - 179 to +29 nt and
with oligonucleotide-1. (a) Labeled -179 to +29 nt was used. 1-Control nuclear
extract; 2-PB-nuclear extract. Analysis was carried out on 6% gels. (b) Labeled
oligonucleotide-l was used. 1-control nuclear extract; 2-PB-nuclear extract.
(c) Labeled oligonucleotide-I was used with PB nuclear extract. 1-No chase;
2-Chased with 500 fold excess of non radioactive oligonucleotide- 1; 3&4-Chased
with 250 and 500 fold excess of oligonucleotide-2 respectively. The complexes
in (b) and (c) were analysed using 9% gels.
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were isolated after RNase-free DNase and proteinase K treatments
followed by Phenol-chloroform extraction and ethanol
precipitation. Supercoiled DNA preparations of the plasmids used
in transcription studies were made by triton X-100 lysis of cells,
phenol: chloroform extraction and sucrose density gradient
centrifugation (13). The RNA transcripts were analysed by the
primer extension method (14). The 5' end labeled primers (primer
2 for CYP2B l/B2 and primer 3 for PEPCK gene transcripts)
were co-precipitated with RNA transcripts and primer extension
reaction carried out with MMLV-reverse transcriptase and other
components. The extended products were analysed on urea (7M)
polyacrylamide gels (12%) and subjected to autoradiography. The
autoradiograms were scanned with laser densitometer and the
relative intensities of the radioactive spots were assessed.
Treatment of animals
Male rats (80 -90g) of the Institute strain were injected with saline
(controls) or phenobarbitone (8 mg/lOOg i.p). The animals were
killed 6 hr after drug treatment and livers processed for isolation
of nuclei.
RESULTS
We have earlier shown that the near 5'-upstream region of
CYP2B1/B2 gene (-179 to + 29 nt) generates a characteristic
gel mobility shift pattern, when assayed with nuclear extracts
from control and PB-treated rat liver (8,15). Although there is
some quantitative variation in the pattern generated by different
extract preparations, it has consistently been observed that the
extracts give two major complexes, with the slower moving top
band being predominant in control nuclear extracts and the faster
moving bottom band being predominant in PB-nuclear extracts.
We have now attempted to localise the DNA element within
- 179nt, responsible for generating this differential gel shift
pattern between control and PB-nuclear extracts. The results
presented in Fig la indicate that excess of non-radioactive
homologous as well as -116 to +29 nt fragments are able to
chase the gel shift pattern generated by the fragment - 179 to
+29 nt but the fragment -75 to +29 nt failed to do so. Next,
several oligonucleotides were tested for their ability to chase the
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Figure 3. Cross-linking analysis of the complexes generated with oligonucleotide- 1.
The proteins after cross-linking were analysed on 10% SDS-PAGE. 1-PB-nuclear
extract. 2-control nuclear extract. The sizes of marker proteins are indicated.
gel shift pattern generated by the fragment - 179 to +29 nt and
oligonucleotide -1 (-69 to -98nt) was found to be most
effective. For example, oligonucleotide-2 (-127 to -160nt) was
not effective in this regard (Fig. Ib).
Oligonucleotide-1 is able to generate a gel shift pattern very
similar to that of the pattern generated by the fragment - 179
to +29 nt (Fig 2a and b). The complexes generated by
oligonucleotide- 1 are chased by excess non-radioactive
oligonucleotide-1 but not by oligonucleotide-2 (Fig.2C).
Cross-linking experiments between the top and bottom
complexes and oligonucleotide- 1 were carried out and the results
presented in Fig 3 indicate that two major protein species
(Mr-42.0 and 39.0 Kd) are perhaps involved in the generation
of the two complexes, since they were eluted together from gels
after performing UV cross-linking analysis. A minor protein band
was seen around 34 Kd. The protein species in control and PB
nuclear extracts interacting with oligonucleotide-1 have the same
electrophoretic mobilities (Fig.3). Further studies on the UV-
crosslinking analysis of each individual complex are needed to
comment on the quantitative aspects of the proteins involved in
control and PB treatments.
In order to examine whether the 5' upstream region covered
by oligonucleotide- 1 (-69 to -98nt) is functionally important,
transcription experiments were carried out with whole nuclei as
well as nuclear extracts. We have earlier shown that the plasmid
pP45Oel79 can be transcribed in whole nuclei and nuclei from
PB-treated rats (PB-nuclei) show a striking increase in the level
of CYP2B1/B2 transcripts derived from exogenous DNA
compared to control nuclei (8, 15). The results presented in Fig.4
indicate that when the upstream is shortened from -179 nt to
-156 nt and then to -116nt, there is an increase by 2.5 to 3.0
fold in the level of the transcript derived from added DNA (170
nt protected fragment). However, when the upstream is further
shortened to -88 and -75nt, there is a four fold decrease in
transcription, indicating the presence of a positive cis-acting
element between - 116 and -75nt. The protected DNA derived
from the endogenous gene transcripts (152 nt) shows a significant
decrease, when exogenous DNA is added. As explained earlier
(8, 15), this is perhaps due to the decreased transcript stability
as a result of the depletion of specific protein factor(s) by the
added DNA. The whole nuclear transcription experiments could
not be carried out in control nuclei, since the CYP2B1/B2
transcripts were barely detectable.
In the second set of experiments, a cell-free transcription system
(12) was used to transcribe Bal3l mutants and to study the effects
of the addition of specific oligonucleotides on transcription. The
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Figure 4. Transcription of Bal3l mutants in whole nuclei isolated from PB-treated
rats. Supercoiled DNAs were used for transcription and the transcripts were
analysed by SI nuclease protection. The lower band (152 nt) corresponds to the
the protected fragment from the endogenous transcript. The upper band (170 nt)
corresponds to the protected fragment from the added DNA. 1 & 6-No DNA
added (endogenous transcript. Lane 6 represents 1/8 the amount in Lane 1);
2-pP45Oe179 DNA; 3-pP450e 1 16DNA; 4-pP45Oe88DNA;
5-pP45Oe75DNA; 7-pP450e156DNA.
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Figure 5. Cell-free transcription analysis. pP450el79 supercoiled DNA was
transcribed using cell-free transcription extracts. In some experiments crude nuclear
extracts were also added. The transcripts were analysed by primer extension and
the arrow indicates position of transcript initiated at + 1. (a) Control transcription
extract was used. 1-No DNA; 2-pP450e179 DNA; 3-pP45OeI79DNA +
control crude nuclear extract; 4-pP450el79 DNA+PB-crude nuclear extract;
5-Treatment 4 + RNase. (b) PB-transcription extract was used. 1-No DNA;
2-pP450el79 DNA; 3-pP450eI79 DNA + control crude nuclear extract;
4-pP450e179 DNA + PB crude nuclear extract.
Figure 6. Transcription of Bal 31 mutants with control and PB-transcription
extracts. (a) Control transcription extract was used (b) PB-transcription extract
was used. I-pP450e 179 DNA; 2-pP450el 16 DNA; 3-pP450e75 DNA. Arrow
indicates position of transcript initiated at + 1.
specific transcripts initiated at +1 nt of CYP2B2 gene were
analysed by primer extension. The bands were quantified using
a laser densitometer. The results presented in Fig.5 a and b
indicate that there is a significant increase in transcription between
control and PB-transcription extracts (nearly 8 fold). Addition
of crude nuclear extracts (obtained with 0.4 M NaCl) stimulates
transcription by both control and PB-transcription extracts. While
the control and PB-transcription extracts show significant
differences in transcription efficiency, the corresponding crude
nuclear extracts are equally effective in stimulating transcription.
The crude nuclear extracts by themselves have very low
transcription activity.
The results presented in Fig.6 indicate that when Bal31 mutants
are transcribed in control transcription extracts, there is some
decrease in transcription when the upstream is shortened from
-179 nt to -116 nt and then to -75 nt. When the mutants are
transcribed in PB-transcription extracts there is 1.5 fold increase
in transcription when the upstream is shortened from -179 nt
to -116 nt, but there is a striking decrease in transcription (nearly
5 fold) when the upstream is further shortened to -75 nt. Thus,
Figure 7. Effect of oligonucleotide-1 and 2 on cell-free transcription. pP450e
179 supercoiled DNA was used for transcription. (a) control transcription extract
was used. 1-No.DNA; 2-pP45Oel79DNA; 3-pP450el79 DNA + 1 Ag of
oligonucleotide-1; 4-pP450e179 + 1 Ag of oligonucleotide-2. (b) PB-transcription
extract was used. 1-pP450e179 DNA; 2-pP45Oe179 DNA + 1 yg of
oligonucleotide-2; 3-pP45Oe179 DNA + 1 4tg of oligonucleotide-1. Arrow
indicates position of transcript initiated at + 1.
Figure 8. Effect of oligonucleotide- 1 and 2 on cell-free transcription in presence
of crude nuclear extracts. (a) Control transcription extract and control crude nuclear
extract were used. (b) PB-transcription extract and PB-crude nuclear extract were
used. 1-pP450e 179 DNA; 2-pP45Oe179 DNA + 1 lg of oligonucleotide-1;
3-pP45Oe179 DNA + 1.5 Ag of oligonucleotide-2. Arrow indicates position
of transcript initiated at + 1.
the results obtained in transcription extracts are in conformity
with those obtained with whole nuclei.
The results on the effects of the addition of oligonucleotides
1 and 2 on transcription of pP45Oel79 in cell-free extracts is
presented in Figs 7 and 8. With control transcription extract, the
oligonucleotides have marginal effects. With PB-transcription
extract, oligonucleotide-I shows a significant inhibition of
transcription, whereas oligonucleotide-2 does not have a
significant effect (Fig.7). In presence of crude nuclear extracts,
the results obtained are exaggerated. Oligonucleotide-l shows
inhibition in both control and PB-transcription systems,the effects
obtained with the latter being more pronounced.
Oligonucleotide-2 shows about 3 and 1.5 fold stimulation in the
case of control and PB-transcription extracts respectively (Fig.8).
Finally, in all these cell-free transcription experiments, another
liver gene construct namely that of phosphoenolpyruvate
carboxykinase (-493 nt to + 73 nt) has been used as a control.
However, the results show that there is no difference in the
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Figure 9. Effect of ax-amanitin on pP450e179 and PEPCK DNAs transcription
in cell-free extracts. (a) PB-transcription extract was used to transcribe pP450e179
DNA. I and 2-without and with cs-amanitin (2ig/ml) respectively (b) PEPCK
DNA was used 1-control transcription extract; 2- PB transcription extract; 3-PB
transcription extract + a-amanitin (2Qg/mn). Arrows indicate position of transcripts
initiated at + lnt. The bottom band seen in b is another primer extended product
and not the primer (primer is not shown).
transcription of this plasmid between control and PB-transcription
extracts. Interestingly while a-amanitin (2Ag/Iml) inhibits
transcription of this DNA strikingly, the transcription of
pP45Oel79 is only partially inhibited (Fig.9).
DISCUSSION
The results of the present investigation have identified the
5'-upstream region of the CYP2B1/B2 gene between -69 nt to
-98nt, to mediate the effects of PB and to play a role in the
basal level transcription of this gene in the uninduced state. This
has been arrived at on the basis of gel retardation analysis, Bal3 1
mutant transcription in whole nuclei and cell-free extracts and
the specific inhibitory effects of oligonucleotide-1 (-69 nt to
-98nt) addition on pP450el79 transcription in cell-free extracts.
Cross-linking experiments of the gel retarded complexes have
indicated two proteins in the Mr range of 42.0 and 39.0 Kd
binding to this region. It is interesting to point out that these
proteins have a significantly lower Mr from the 85 Kd (8),
subsequently revised to 95 Kd protein (15), binding to the entire
upstream fragment of -179 nt in western analysis after SDS-PA-
GE. Since, oligonucleotide-1 mimics the gel mobility shift pattern
of the 179 nt fragment, we suspect that the 95 Kd protein may
have a low affinity for the DNA in the native state and as such
may not be directly binding to DNA.
Although the results have clearly identified the region between
-69 nt and -98 nt as a positive cis-acting element, there are
indications of other regions within -179 nt being involved. For
example, there is some increase in transcription when the
upstream is shortened from -179 nt to- 116 nt in PB-nuclei or
PB-transcription extracts. However, this is not evident in control
transcription extracts, although the results obtained with control
transcription extract need careful evaluation in view of the low
levels of basal transcription perhaps due to the limiting amounts
of the positive trans acting factor(s) interacting with the
oligonucleotide-I region. However, oligonucleotide-2 addition
shows stimulation of pP45Oe179 DNA transcription in cell-free
extracts especially in the presence of crude nuclear extracts (Fig
8). There is thus the possibility of a negative transcription element
being present between -179 nt and -116 nt and PB treatment
may modulate interaction of specific factors with this element.
The cell-free transcription system is able to manifest a
significant difference in the transcription of pP450e179 DNA
between control and PB-treatment and, therefore, is quite suitable
for the analysis of cis-acting elements and transacting factors.
However, it should be pointed out that at the level of whole nuclei,
the difference between uninduced and induced states is much
more marked (8, 15). The transcripts in control nuclei are barely
detectable. Thus, chromatin conformation and stability of
transcripts may also contribute to the difference between control
and PB-treated condition in vivo and at the level of intact nuclei.
The partial sensitivity of the cell-free transcription system to
a-amanitin in the transcription of CYP2B2 gene 5'-upstream
region is rather intriguing. In a different study, we have found
that even under run on transcription conditions, transcription of
the first exon of the CYP2B1/B2 gene is only partially sensitive
to oa-amanitin, but the transcription of the 9th exon is fully
sensitive (unpublished data). The reasons for this result as well
as the generation of multiple bands in primer extension analysis
are under investigation. However, the transcripts initiated at +1
nt show up prominently and respond to treatment conditions
appropriately. Multiple bands in addition to the transcripts
initiated at +1 nt, in primer extension analysis have been
observed in other systems as well (9, 17).
In a recent study, He and Fulco (16) have shown that a
barbiturate-regulated protein binds to a common sequence in the
cytochrome P450 genes of Bacillus megaterium and rat
cytochrome P450 (barbiturate-inducible). They have identified
a 17 nt sequence, which is part of the foot-print reported by us
(8) and is within the oligonucleotide-l reported in the present
study. We have preliminary evidence (unpublished data) to
suggest that difference in the levels of the two major complexes
seen in gel mobility shift assays with oligonucleotide-l and
nuclear extracts obtained from control and PB-treated rat livers
are governed by the phosphorylation status of the proteins
involved. The cycloheximide-sensitivity of the PB-mediated
effects reported earlier (8) appear to govern the phosphorylation
machinery rather than the synthesis of the transcription factor
(s) itself, thus influencing the phosphorylation status of the
transcription factors and their binding to the DNA. Therefore,
the phosphorylation status of the protein factors binding to the
oligonucleotide-l region appears to be atleast one of the important
parameters governing the uninduced or induced state of the gene.
It is thus a possiblity that phenobarbitone may be acting by
modulating the phosphorylation status of the transcription factors
involved rather than acting directly through a PB-responsive
element in the target cytochrome P450 gene.
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